Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-003418-16Phase 2Active
Phase 2, randomised, double-blind trial in gastroesophageal reflux disease (GERD) comparing Baclofen with Placebo (2 arms). Primary endpoint: Rate of acid and non-acid reflux episodes. Started Jul 2006; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-003418-16.